Brief: Nevakar Injectables Receives U.S. FDA Approval Of Ready-To-Use Ephedrine Injection
28/04/2022 12:50
April 28 (Reuters) - Endo International PLC ENDP.O :
* NEVAKAR INJECTABLES RECEIVES U.S. FDA APPROVAL OF
READY-TO-USE
EPHEDRINE INJECTION IN A PREFILLED SYRINGE
Source text for Eikon: ID:nGNX16HYRc
Further company coverage: ENDP.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Endo International
See all newsBrief: Endo International PLC Files For Offering Of Up To 31.1 Million Common Shares By The Selling Stockholders - SEC Filing
Brief: Par Pharmaceutical Issues Voluntary Nationwide Recall Of Seven Lots Of Treprostinil Injection
Brief: Endo International Says Wholly-Owned Subsidiary Endo Finance Priced Its $1.5 Bln Senior Secured Seven-Year Term Loan
Brief: Endo, Inc. Announces Pricing Of $1 Bln Of Senior Secured Notes
Brief: Endo Announces Proposed Private Offering Of Senior Secured Notes